Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
2000 1
2001 1
2004 2
2005 1
2006 2
2007 1
2010 3
2011 5
2012 1
2013 3
2014 5
2015 2
2016 2
2017 7
2018 11
2019 7
2020 4
2021 1
2022 4
2023 2
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial.
Cambron M, Mostert J, D'Hooghe M, Nagels G, Willekens B, Debruyne J, Algoed L, Verhagen W, Hupperts R, Heersema D, De Keyser J; FLUOX-PMS Study Group. Cambron M, et al. Mult Scler. 2019 Nov;25(13):1728-1735. doi: 10.1177/1352458519843051. Epub 2019 Jun 20. Mult Scler. 2019. PMID: 31218911
Neuropalliative care in times of war.
Rukavina K, Oliver DJ, Guijarro-Castro C, Tudor KI, Veronese S, Vanopdenbosch L; European Academy of Neurology Scientific Panel Palliative Care. Rukavina K, et al. Among authors: vanopdenbosch l. Eur J Neurol. 2022 Oct;29(10):3130-3131. doi: 10.1111/ene.15383. Epub 2022 May 16. Eur J Neurol. 2022. PMID: 35510741 No abstract available.
Hemorrhagic transformation in acute ischemic stroke: hemorrhagic subtypes and symptomatic intracranial hemorrhage.
Luff MK, Khezri N, Miralbes S, Naravetla B, Spiotta AM, Loehr C, Martínez-Galdámez M, McTaggart RA, Defreyne L, Vega P, Zaidat OO, Price LL, Gupta R, Möhlenbruch MA, Liebeskind DS; ASSIST Investigators. Luff MK, et al. J Neurointerv Surg. 2024 Jul 5:jnis-2024-021725. doi: 10.1136/jnis-2024-021725. Online ahead of print. J Neurointerv Surg. 2024. PMID: 38969497
Vascular aspects of multiple sclerosis.
D'haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. D'haeseleer M, et al. Among authors: vanopdenbosch l. Lancet Neurol. 2011 Jul;10(7):657-66. doi: 10.1016/S1474-4422(11)70105-3. Lancet Neurol. 2011. PMID: 21683931 Review.
Corticosteroids in the management of acute multiple sclerosis exacerbations.
Smets I, Van Deun L, Bohyn C, van Pesch V, Vanopdenbosch L, Dive D, Bissay V, Dubois B; Belgian Study Group for Multiple Sclerosis. Smets I, et al. Among authors: vanopdenbosch l. Acta Neurol Belg. 2017 Sep;117(3):623-633. doi: 10.1007/s13760-017-0772-0. Epub 2017 Apr 8. Acta Neurol Belg. 2017. PMID: 28391390 Review.
A 36-Year-Old Man with Persistent Headache.
Matthijs V, Vandenbussche N, Vanopdenbosch L. Matthijs V, et al. Among authors: vanopdenbosch l. NEJM Evid. 2024 Sep;3(9):EVIDmr2400172. doi: 10.1056/EVIDmr2400172. Epub 2024 Aug 27. NEJM Evid. 2024. PMID: 39189862
ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS. Hartung HP, et al. Among authors: vanopdenbosch l. J Neurol. 2024 Jul;271(7):4348-4360. doi: 10.1007/s00415-024-12326-z. Epub 2024 Apr 22. J Neurol. 2024. PMID: 38649522 Free PMC article. Clinical Trial.
67 results